Effect of sodium salicylate and acetylsalicylic acid on epicardial ST-segment elevation during coronary artery occlusion in dogs

References

• Alexander W. D., MacDougall A. I., Oliver M. F., Boyd G. S. The effect of salicylate on the serum lipids and lipoproteins in coronary artery disease. Clin. Sci. 1959; 18: 195
   PubMedGoogle Scholar
• Angell C. S., Lakatta E. G., Weisfeldt M. L., Shock N. W. Relationship of intramyocardial oxygen tension and epicardial ST segment changes following acute coronary artery ligation: effects of coronary perfusion pressure. Circulat. Res. 1975; 9: 12
   Google Scholar
• Bing R. J., Siegel A., Ungar I., Gilbert M. Metabolism of the human heart. II. Studies on fat ketone and amino acid metabolism. Amer. J. Med. 1954; 16: 504
   PubMed Web of Science ®Google Scholar
• Boston Collaborative Drug Surveillance Group: Regular aspirin intake and acute myocardial infarction. Brit. med. J. 1974; 1: 440
   PubMed Web of Science ®Google Scholar
• Braunwald E., Maroko P. R. The reduction of infarct size—an idea whose time (for testing) has come. Circulation 1974; 50: 206
   PubMed Web of Science ®Google Scholar
• Brody T. M. Action of sodium salicylate and related compounds on tissue metabolism in vitro. J. Pharmacol. exp. Ther. 1956; 117: 39
   PubMed Web of Science ®Google Scholar
• Carlson L. A., østman J. Effect of salicylates on plasma free fatty acid in normal and diabetic subjects. Metabolism 1961; 10: 781
   PubMed Web of Science ®Google Scholar
• Challoner D. R., Steinberg D. Oxidative metabolism as influenced by fatty acids and epinephrine. Amer. J. Physiol. 1966; 211: 897
   Web of Science ®Google Scholar
• Dole V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. clin. Invest. 1956; 35: 150
   PubMed Web of Science ®Google Scholar
• Elwood P. C., Cochrane A. L., Burr M. L., Sweetnam P. M., Williams G., Welsby E., Hughes S. J., Renton R. A. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Brit. Med. J. 1974; 1: 436
   PubMed Web of Science ®Google Scholar
• Evans G., Packham M., Nishizawa E., Mustard J., Murphy E. The effect of acetylsalicylic acid on platelet function. J. exp. Med. 1969; 128: 877
   Google Scholar
• Hough F. S., Gevers W. Catecholamine release as mediator of intracellular enzyme activation in ischaemic perfused rat hearts. S. Afr. Med. J. 1975; 49: 538
   PubMed Web of Science ®Google Scholar
• Jennings R. B. Early phase of myocardial ischemic injury and infarction. Amer. J. Cardiol. 1969; 24: 753
   PubMed Web of Science ®Google Scholar
• Kjekshus J. K., Maroko P. R., Sobel B. E. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc. Res. 1972; 6: 490
   PubMed Web of Science ®Google Scholar
• Kjekshus J. K., Mjøs O. D. Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J. clin. Invest. 1972; 51: 1767
   PubMed Web of Science ®Google Scholar
• Kjekshus J. K., Mjøs O. D. Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion. J. clin. Invest. 1973; 52: 1770
   PubMed Web of Science ®Google Scholar
• Kurien V. A., Oliver M. F. A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet 1970; 1: 813
   PubMed Web of Science ®Google Scholar
• Lassers B. W., Carlson L. A., Kaijser L., Wahlquist M. The nature and control of myocardial substrate metabolism in healthy man. Effects of Acute Ischaemia on Myocardial Function, M. F. Oliver, D. G. Julian, K. W. Donald. Churchill Livingstone, Edinburgh 1972
   Google Scholar
• Lekven Ilebekk J. A., Fonstelien E., Kiil F. Relationship between ST-segment elevation and local tissue flow during myocardial ischaemia in dogs. Circulat. Res. 1975; 9: 627
   Google Scholar
• Maroko P. R., Braunwald E. Modification of myocardial infarction size after coronary occlusion. Ann. Intern. Med. 1973; 79: 720
   PubMed Web of Science ®Google Scholar
• Maroko P. R., Kjekshus J. K., Sobel B. E., Watanabe T., Covell J. W., Ross J., Braunwald E. Factors influencing infarct size following experimental coronary artery occlusion. Circulation 1971; 43: 67
   PubMed Web of Science ®Google Scholar
• Maroko P. R., Libby P., Ginks W. R., Bloor C. M., Shell W. E., Sobel B. E., Ross J. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J. clin. Invest. 1972; 51: 2710
   PubMed Web of Science ®Google Scholar
• Mjøs O. D. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J. clin. Invest. 1971; 50: 1386
   PubMed Web of Science ®Google Scholar
• Mjøs O. D., Kjekshus J. K., Lekven J. Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. J. clin. Invest. 1974; 53: 1290
   PubMed Web of Science ®Google Scholar
• Mjøs O. D., Miller N. E., Riemersma R. A., Oliver M. F. Effects of dichloroacetate on myocardial substrate extraction, epicardial ST-segment elevation, and ventricular blood flow following coronary occlusion in dogs. Cardiovasc. Res. 1976; 10: 427
   PubMedGoogle Scholar
• Mjøs O. D., Miller N. E., Riemersma R. A., Oliver M. F. Effects of p-chlorophenoxyisobutyrate on myocardial free fatty acid extraction, ventricular blood flow, and epicardial ST-segment elevation during coronary occlusion in dogs. Circulation 1976; 54: 494
   PubMedGoogle Scholar
• Moore S. Platelet aggregation secondary to coronary obstruction. Circulation 1976; 54: 66, Suppl. I.
   Google Scholar
• Moschos C. B., Haider B., Catalino D. C., Regan T. J. Effects of aspirin upon experimental nonthrombotic coronary occlusion. (Abstract). Circulation 1975; 52: 145, Suppl. II.
   Google Scholar
• Moschos C. B., Lahiri K., Lyons M., Weisse A. B., Oldewurtel H. A., Regan T. J. Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery. Effect of aspirin, dipyridamole and thrombolysis. Amer. Heart J. 1973; 86: 61
   PubMedGoogle Scholar
• Muller J. E., Maroko P. R., Braunwald E. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation 1975; 52: 16
   PubMed Web of Science ®Google Scholar
• Nakano J. General pharmacology of prostaglandins. The Prostaglandins. Pharmacological and Therapeutic Advances, M. F. Cuthbert. William Heinemann Medical Books Ltd, London 1973
   Google Scholar
• Opie L. H. The glucose hypothesis: relation to acute myocardial ischemia. J. Mol. cell. Cardiol. 1970; 1: 107
   Google Scholar
• Opie L. H., Owen P., Riemersma R. A. Relative rates of oxidation of glucose and free fatty acids by ischaemic and non-ischaemic myocardium after coronary artery ligation in the dog. Europ. J. clin. invest 1973; 3: 419
   PubMed Web of Science ®Google Scholar
• Page D. L., Caulfleld J. B., Kastor J. A., De Sanctis R. W., Sanders C. A. Myocardial changes associated with cardiogenic shock. New Engl J. Med. 1971; 285: 133
   PubMed Web of Science ®Google Scholar
• Sayen J. J., Sheldon W. F., Peirce G., Kuo P. T. Polarographic oxygen, the epicardial electrocardiogram and muscle contraction in experimental acute regional ischemia of the left ventricle. Circulat. Res. 1958; 6: 779
   PubMed Web of Science ®Google Scholar
• Shahab L., Wollenberger A., Krause E. G., Genz S. The effect of acute ischaemia on catecholamines and cyclic AMP levels in normal and hypertrophied myocardium. Effect of Acute Ischaemia on Myocardial Function, M. F. Oliver, D. G. Julian, K. W. Donald. Churchill Livingstone, Edinburgh 1972
   Google Scholar
• Sonnenblick E. H., Ross J., Jr, Braunwald E. Oxygen consumption of the heart. Newer concepts of its multifactorial determination. Amer. J. Cardiol. 1968; 22: 328
   PubMed Web of Science ®Google Scholar
• Snedecor G. W., Cochran W. G. Statistical Methods6th Ed. The Iowa State University Press, Ames 1967
   Google Scholar
• Talesnik J., Sunahara F. A. Enhancement of metabolic coronary dilatation by aspirin-like substances by suppression of prostaglandin feedback control?. Nature 1973; 244: 351
   PubMedGoogle Scholar
• Tenney S. M., Miller R. M. The respiratory and circulatory actions of salicylate. Amer. J. Med. 1955; 19: 498
   PubMed Web of Science ®Google Scholar
• Trinder P. Rapid determination of salicylate in biological fluids. Biochem. J. 1954; 57: 301
   PubMed Web of Science ®Google Scholar
• Trout D. L., Estes E. H., Jr., Friedberg S. J. Titration of free fatty acids of plasma: a study of current methods and a new modification. J. Lipid Res. 1960; 1: 199
   PubMed Web of Science ®Google Scholar
• Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232
   Web of Science ®Google Scholar
• Vetter N. J., Strange R. C., Adams W., Oliver M. F. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 1: 284
   PubMedGoogle Scholar
• Vik-Mo H., Mjøs O. D. Myocardial metabolism and performance during sodium salicylate infusion in dogs. Scand. J. clin. Lab. Invest. 1976; 36: 763
   PubMed Web of Science ®Google Scholar
• Weiss H. J., Aledort L. M., Kochwa S. The effect of salicylates on the haemostatic properties of platelets in man. J. clin. Invest. 1968; 47: 2169
   PubMed Web of Science ®Google Scholar